David A. Tuveson

Oncology
1 Bungtown Rd
Cold Spring Harbor, NY 11724

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 201 publications

Fibroblasts: a diverse population of cells balancing homeostasis, wound healing, regeneration, inflammation, fibrosis, and cancer across organs.

Fibroblasts: a diverse population of cells balancing homeostasis, wound healing, regeneration, inflammation, fibrosis, and cancer across organs.

Journal: JCI insight
Published: July 08, 2026

Stress-induced CXCL13 regulates pancreatic exocrine homeostasis, age-related chronic inflammation, and cancer progression.

Stress-induced CXCL13 regulates pancreatic exocrine homeostasis, age-related chronic inflammation, and cancer progression.

Journal: Science advances
Published: May 01, 2026

Implantable Microdevices for In Vivo Assessment of Chemotherapy Response in Patient Derived Organoid Orthotopic Pancreatic Cancer Models.

Implantable Microdevices for In Vivo Assessment of Chemotherapy Response in Patient Derived Organoid Orthotopic Pancreatic Cancer Models.

Journal: Annals of surgery
Published: December 26, 2025

MYC-Mediated USP39 Upregulation Stabilizes SRSF1 in Pancreatic Cancer.

MYC-Mediated USP39 Upregulation Stabilizes SRSF1 in Pancreatic Cancer.

Journal: Molecular cancer research : MCR
Published: October 10, 2025

Mitochondrial-Localized Keratin 17 Promotes Chemoresistance in Basal-like Pancreatic Cancer.

Mitochondrial-Localized Keratin 17 Promotes Chemoresistance in Basal-like Pancreatic Cancer.

Journal: Cancer research
Published: October 06, 2025

Mitochondrial-Localized Keratin 17 Promotes Chemoresistance in Basal-Like Pancreatic Cancer.

Mitochondrial-Localized Keratin 17 Promotes Chemoresistance in Basal-Like Pancreatic Cancer.

Journal: Cancer research
Published: October 06, 2025

Brain metastasis from KRAS wild-type pancreatic cancer and organoid correlates: a case report.

Brain metastasis from KRAS wild-type pancreatic cancer and organoid correlates: a case report.

Journal: Journal of gastrointestinal oncology
Published: October 03, 2025

Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.

Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 24, 2025

PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.

PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 10, 2025

MYC-Driven Activation of USP39 Enhances SRSF1 Stability and Promotes PDAC Progression.

MYC-Driven Activation of USP39 Enhances SRSF1 Stability and Promotes PDAC Progression.

Journal: bioRxiv : the preprint server for biology
Published: September 05, 2025

AUM-302, a novel triple PIM/PI3K/mTOR inhibitor, synergizes with RAS inhibition and impedes the growth of pancreatic ductal adenocarcinoma spheroids and organoids.

AUM-302, a novel triple PIM/PI3K/mTOR inhibitor, synergizes with RAS inhibition and impedes the growth of pancreatic ductal adenocarcinoma spheroids and organoids.

Journal: Frontiers in pharmacology
Published: August 13, 2025

Inference of Genetic Ancestry from Cancer-Derived Molecular Data with RAIDS.

Inference of Genetic Ancestry from Cancer-Derived Molecular Data with RAIDS.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: August 08, 2025
Showing 1-12 of 201

Last Updated: 09/26/2026